Literature DB >> 16331816

[Telomerase activity and telomere length in CD4+,CD8+ and CD19+ lymphocytes from patients with systemic lupus erythematosus].

Jin Lin1, Jue Xie, Wen-bin Qian.   

Abstract

OBJECTIVE: To investigate the telomerase activity and the telomere length in CD4(+), CD8(+) and CD19(+) lymphocytes from patients with systemic lupus erythematosus (SLE).
METHODS: Telomerase activity of CD4(+), CD8(+) and CD19(+) cells from patients with SLE and normal controls was examined by telomeric repeats amplification protocol. Telomere length in those cells was measured by Southern blot method. RESULT: CD4(+), CD8(+) and CD19(+) cells in patients with SLE showed high telomerase activity, but only telomerase activity of CD19(+) cells was significantly higher than that in controls. The length of telomere in CD4(+) and CD8(+) cells was significantly shorter than that in controls, but not in CD19(+) cells.
CONCLUSION: Higher telomerase activity in CD19(+) cells and shortened telomere length in CD4(+) and CD8(+) cells of patients with SLE may be associated with pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331816     DOI: 10.3785/j.issn.1008-9292.2005.06.012

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  3 in total

1.  Association between shortened telomere length and rheumatoid arthritis : A meta-analysis.

Authors:  Y H Lee; S-C Bae
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

2.  Expression Pattern of Telomerase Reverse Transcriptase (hTERT) Variants and Bcl-2 in Peripheral Lymphocytes of Systemic Lupus Erythematosus Patients.

Authors:  Armin Attar; Mohsen Khosravi Maharlooei; Mohammad Ali Nazarinia; Ahmad Hosseini; Zohre Bajalli; Yalda Sadat Moeini; Ahmad Monabati; Fatemeh Amirmoezi; Mansooreh Jaberipour; Mojtaba Habibagahi
Journal:  Iran J Pathol       Date:  2020-04-21

Review 3.  Telomerase and telomeres in aging theory and chronographic aging theory (Review).

Authors:  Mayya P Razgonova; Alexander M Zakharenko; Kirill S Golokhvast; Maria Thanasoula; Evangelia Sarandi; Konstantinos Nikolouzakis; Persefoni Fragkiadaki; Dimitris Tsoukalas; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Mol Med Rep       Date:  2020-06-25       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.